The native heart valves are adaptive living tissues that are capable of growth and remodeling in response to changes in the hemodynamic environment. It is the intrinsic lack of this growth and remodeling capacity that causes current heart valve replacements to fail over time. Therefore, heart valve tissue engineering (HVTE) is being pursued with the aim of creating living, autologous replacement valves with the capacity for somatic growth and increased valve longevity. This chapter elaborates on the various HVTE paradigms, ranging from the in vitro creation of living valves to the use of acellular valvular grafts that are designed to induce endogenous regeneration in situ. This includes a delineation of the various cell types, scaffolds, an...
A tissue engineered heart valve (TEHV) could serve as a living, implantable valve replacement that w...
Valvular heart disease is an increasing population health problem and, especially in the elderly, a ...
Engineered heart valves promise to be the ideal heart valve replacement: they have the potential to ...
The native heart valves are adaptive living tissues that are capable of growth and remodeling in res...
Heart valve replacement represents the most common surgical therapy for end-stage valvular heart dis...
Well documented shortcomings of current heart valve substitutes – biological and mechanical prosthes...
Heart valve disease is a major health burden, treated by either valve repair or valve replacement, d...
Background: Heart valve disease is a clinically serious condition. The replacement of damaged valves...
The development of viable and functional tissue-engineered heart valves (TEHVs) is a challenge that,...
Heart valve replacement is often the only solution for patients suffering from valvular heart diseas...
Abstract—Tissue-engineered heart valves have been proposed by physicians and scientists alike to be ...
Valvular heart disease remains to be a major cause of death worldwide with increasing prevalence, mo...
Background— Tissue engineering represents a promising approach for the development of living heart v...
Valvular heart disease is an important cause of morbidity and mortality, and currently available sub...
A tissue engineered heart valve (TEHV) could serve as a living, implantable valve replacement that w...
Valvular heart disease is an increasing population health problem and, especially in the elderly, a ...
Engineered heart valves promise to be the ideal heart valve replacement: they have the potential to ...
The native heart valves are adaptive living tissues that are capable of growth and remodeling in res...
Heart valve replacement represents the most common surgical therapy for end-stage valvular heart dis...
Well documented shortcomings of current heart valve substitutes – biological and mechanical prosthes...
Heart valve disease is a major health burden, treated by either valve repair or valve replacement, d...
Background: Heart valve disease is a clinically serious condition. The replacement of damaged valves...
The development of viable and functional tissue-engineered heart valves (TEHVs) is a challenge that,...
Heart valve replacement is often the only solution for patients suffering from valvular heart diseas...
Abstract—Tissue-engineered heart valves have been proposed by physicians and scientists alike to be ...
Valvular heart disease remains to be a major cause of death worldwide with increasing prevalence, mo...
Background— Tissue engineering represents a promising approach for the development of living heart v...
Valvular heart disease is an important cause of morbidity and mortality, and currently available sub...
A tissue engineered heart valve (TEHV) could serve as a living, implantable valve replacement that w...
Valvular heart disease is an increasing population health problem and, especially in the elderly, a ...
Engineered heart valves promise to be the ideal heart valve replacement: they have the potential to ...